LYMPHOBLASTIC LYMPHOMA, REFRACTORY

Clinical trials for LYMPHOBLASTIC LYMPHOMA, REFRACTORY explained in plain language.

Never miss a new study

Get alerted when new LYMPHOBLASTIC LYMPHOMA, REFRACTORY trials appear

Sign up with your email to follow new studies for LYMPHOBLASTIC LYMPHOMA, REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo tested in kids with Tough-to-Treat leukemia

Disease control Recruiting now

This early-stage study aims to find the safest and most effective dose of a drug called venetoclax when given alongside standard chemotherapy. It is for children, teens, and young adults up to age 40 with high-risk blood cancers like leukemia and myelodysplastic syndrome (MDS) th…

Matched conditions: LYMPHOBLASTIC LYMPHOMA, REFRACTORY

Phase: PHASE1 • Sponsor: Andrew E. Place, MD • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

LYMPHOBLASTIC LYMPHOMA, REFRACTORY

Get alerted when new LYMPHOBLASTIC LYMPHOMA, REFRACTORY trials appear

New drug combo tested in kids with Tough-to-Treat leukemia